COMy - The 8th world Congress on Controversies in Multiple Myeloma
May 12, 2022 ‐ May 15, 2022 in Paris, France
The 8th world Congress on Controversies in Multiple Myeloma will take place from May 12-15, 2022 both in-person and virtually.
David Sourdive, PhD, EVP CMC and Manufacturing, Roman Galetto,PhD, Director, Preclinical and Program Management & Katie Newhall, PhD, Vice President Translational Sciences will present on Saturday, May 14th at 8:30AM CET, in a presentation entitled, "Innovation for Patients with Relapsed/Refractory Multiple Myeloma: Development of TALEN gene-edited Allogeneic CAR-T Therapies Targeting CS1."
To register, click here: https://comylive.cme-congresses.com/registration/